LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.93
EUR
0.07
EUR
2.46 %
15.07.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 3.31 USD | -0.06 USD | -1.77 % |
|---|
| Vortag | 3.36 USD | Datum | 13.07.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Injective Staking ETP | CH1360612134 | 65.03% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 46.98% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 45.69% | |
| 21Shares Pendle ETP | CH1495416997 | 37.92% | |
| 21Shares Jupiter ETP | CH1480821383 | 21.25% | |
| 21Shares Ondo ETP | CH1396389921 | 20.52% | |
| 21Shares Stellar ETP | CH1109575535 | 16.64% | |
| 21shares Gram Staking ETP | CH1297762812 | 15.95% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | -9.25% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | -10.96% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 142.65% | |
| 21shares Morpho ETP | CH1506167027 | 41.84% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 10.71% | |
| 21shares Gram Staking ETP | CH1297762812 | -7.39% | |
| 21shares Canton Network ETP | CH1503127917 | -12.38% | |
| 21Shares Injective Staking ETP | CH1360612134 | -12.54% | |
| 21Shares Jupiter ETP | CH1480821383 | -14.95% | |
| 21Shares Bittensor ETP | CH1495416971 | -32.53% | |
| 21Shares Pendle ETP | CH1495416997 | -34.76% | |
| 21Shares XDC Network ETP | CH1464217285 | -40.77% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | -5.23% | |
| 21Shares Binance BNB ETP | CH0496454155 | -19.08% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -22.33% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | -37.73% | |
| 21Shares Ethereum Staking ETP | CH0454664027 | -38.35% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -49.50% | |
| 21Shares Injective Staking ETP | CH1360612134 | -60.96% | |
| 21Shares Dogecoin ETP | CH1431521033 | -64.23% | |
| 21Shares XDC Network ETP | CH1464217285 | -67.03% | |
| 21Shares Immutable ETP | CH1360612142 | -76.05% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 126.07% | |
| 21Shares Stellar ETP | CH1109575535 | 92.28% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 50.01% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 29.17% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 10.00% | |
| 21Shares Sui Staking ETP | CH1360612159 | 1.28% | |
| 21Shares Injective Staking ETP | CH1360612134 | -75.68% | |
| 21Shares Immutable ETP | CH1360612142 | -89.99% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 911’116.72 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 15.07.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 60.10 | |
| Performance 2 Jahre | 59.01 | |
| Performance 3 Jahre | 8.65 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |